An immune-related gene pair signature predicts the prognosis and immunotherapeutic response in glioblastoma.

Autor: Wang G; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Man Y; Department of Medical Oncology, Beidahuang Industry Group General Hospital, Harbin, China., Cao K; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Zhao L; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Lun L; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Chen Y; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Zhao X; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Wang X; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Zhang L; Department of Medical Oncology, Beidahuang Industry Group General Hospital, Harbin, China., Hao C; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.

Publikováno v: Heliyon [Heliyon] 2024 Oct 05; Vol. 10 (19), pp. e39025. Date of Electronic Publication: 2024 Oct 05 (Print Publication: 2024).

Re: Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China. R. Shi, Q. Xie, X. Gang, J. Lun, L. Cheng, A. Pantuck and J. Rao. J Urol 2008; 179: 610-615

Autor: A T, Ozdemir, E C, Serefoglu, M D, Balbay

Publikováno v: The Journal of urology. 180(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a9c36c69e4da3e226c936638eaa6545f
https://pubmed.ncbi.nlm.nih.gov/18082217

Feasibility of omitting contralateral neck irradiation in patients with node-negative sinonasal squamous cell carcinoma crossing the midline.

Autor: Liu Q; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Lun L; Department of Head and Neck Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China., Sun M; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang Z; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Qu Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Huang X; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Chen X; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang K; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wu R; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Yi J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Luo J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Publikováno v: Head & neck [Head Neck] 2023 Sep; Vol. 45 (9), pp. 2237-2245. Date of Electronic Publication: 2023 Jul 14.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.